galantamine hydrobromide

Also found in: Dictionary.

galantamine hydrobromide

Razadyne, Razadyne ER, Reminyl (UK), Reminyl XL (CA) (UK)

Pharmacologic class: Cholinesterase inhibitor

Therapeutic class: Anti-Alzheimer's agent

Pregnancy risk category B


Unclear. May reversibly inhibit acetylcholinesterase, increasing concentration of acetylcholine (necessary for nerve impulse transmission) in brain synapses.


Capsules (extended-release): 8 mg, 16 mg, 24 mg

Oral solution: 4 mg/ml

Tablets: 4 mg, 8 mg, 12 mg

Indications and dosages

Mild to moderate dementia of Alzheimer's disease

Adults: Initially, 4 mg P.O. b.i.d. If patient tolerates dosage well after at least 4 weeks of therapy, increase to 8 mg P.O. b.i.d. May increase to 12 mg P.O. b.i.d. after at least 4 weeks at previous dosage. Recommended range is 16 to 24 mg daily in two divided doses. Or initially, 8 mg P.O. daily (Razadyne ER). If patient tolerates dosage after at least 4 weeks, increase to 16 mg P.O. daily. Further increase to 24 mg P.O. daily should be attempted after minimum of 4 weeks at 16 mg/day.

Dosage adjustment

• Moderate hepatic or renal impairment

Off-label uses

• Vascular dementia


• Hypersensitivity to drug

• Severe hepatic or renal impairment

• Pregnancy or breastfeeding

• Children


Use cautiously in:

• asthma, chronic obstructive pulmonary disease, GI bleeding, moderate hepatic or renal impairment, Parkinson's disease, seizures.


• Before giving, make sure patient is well hydrated, to minimize GI upset.

• Give with morning and evening meals.

• Give with antiemetics as needed.

• Use pipette to add oral solution to beverage; have patient drink it right away.

Adverse reactions

CNS: depression, dizziness, headache, tremor, insomnia, drowsiness, fatigue, syncope

CV: bradycardia

EENT: rhinitis

GI: nausea, vomiting, diarrhea, abdominal pain, dyspepsia, anorexia

GU: urinary tract infection, hematuria

Hematologic: anemia

Other: weight loss


Drug-drug Anticholinergics: antagonism of anticholinergic activity

Cholinergics: synergistic effects

Cimetidine, erythromycin, ketoconazole, paroxetine: increased galantamine bioavailability

Patient monitoring

• Assess fluid intake and output to ensure adequate hydration, which helps reduce GI upset.

• Monitor cognitive status.

• Evaluate patient for cardiac conduction abnormalities. Assess pulse regularly for bradycardia.

• Observe for bleeding tendencies.

Assess for depression and suicidal ideation.

Patient teaching

• Instruct caregiver in proper technique for using oral pipette.

• Teach caregiver how to measure patient's pulse. Tell him to report slow pulse right away.

• Recommend frequent, small servings of healthy food and adequate fluids to minimize GI upset.

Tell patient or caregiver to watch for and report signs and symptoms of depression.

• Advise patient or caregiver to establish effective bedtime routine.

• Caution caregiver to prevent patient from performing hazardous activities until adverse reactions are known.

• As appropriate, review all other significant adverse reactions and interactions, especially those related to the drugs mentioned above.

Mentioned in ?
References in periodicals archive ?
Galantamine hydrobromide was used as inhibitor of the enzymes.
The report includes galantamine hydrobromide description, covers its application areas and related patterns.
The company's abbreviated new drug application was approved for galantamine hydrobromide in 8-, 16- and 24-mg forms.